Veeva Systems (VEEV) 44th Annual J.P. Morgan Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
44th Annual J.P. Morgan Healthcare Conference summary
13 Jan, 2026Vision and Values
Strives to build the industry cloud for life sciences, integrating software, data, and consulting to enhance efficiency across R&D, manufacturing, and commercial functions.
Operates as a public benefit corporation, balancing the interests of shareholders, customers, employees, and society, and prioritizing ethical practices and stakeholder value.
Core values include integrity, customer success, employee success, speed, and long-term impact.
Portfolio and Market Opportunity
Serves a $20 billion market with about 16% penetration, indicating significant growth potential.
Offers over 50 mission-critical products across Development, Quality, Commercial, and Data Clouds, plus business consulting.
Products are deeply integrated, tailored for the highly regulated life sciences sector, and provide a structural advantage through systems of record and product excellence.
Competitive Advantages and Operating Model
Emphasizes the suite effect, where integrated products drive customer retention and expansion.
Maintains low marketing spend due to strong reference selling from satisfied customers.
Unique in combining specialist depth with platform scale, unlike most niche competitors.
Execution is driven by focused teams, leadership, and a unique operating model centered on customer success.
Latest events from Veeva Systems
- FY 2026 revenue and net income rose sharply, with robust outlook and accelerating AI-driven growth.VEEV
Q4 20265 Mar 2026 - All proposals were recommended for approval, with voting results to be filed publicly.VEEV
AGM 20243 Feb 2026 - Growth accelerates as unified platform, AI, and new products expand market share and customer value.VEEV
Baird 2024 Global Consumer, Technology & Services Conference1 Feb 2026 - Integrated platform and data innovation fuel durable growth and leadership in life sciences.VEEV
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q2 revenue up 15% year-over-year, with strong margins and raised FY2025 guidance.VEEV
Q2 202523 Jan 2026 - Vault CRM and unified platforms drive growth as life sciences invests in innovation.VEEV
Citi's 2024 Global TMT Conference22 Jan 2026 - 2030 revenue goal set at $6B, with organic growth and new market expansion as key drivers.VEEV
Investor Day 202415 Jan 2026 - Q3 revenue up 13% to $699M, 43.5% margin, strong subscription and AI-driven growth.VEEV
Q3 202511 Jan 2026 - Integrated innovation and disciplined growth drive confidence in $6B revenue targets by 2030.VEEV
Raymond James 2024 TMT & Consumer Conference11 Jan 2026